`
`E uivalent of Form PTO/SB/08b 7-09)
`Com: lete i Known
`
`FIRST SUPPLEMENTAL
`
`INFORMATION DISCLOSURE
`
`—§§pfil:?tiifiiu§3:rWV
`
`2
`
`STATEMENT BY APPLICANT
`(Use as many sheets as necessary)
`
`NATARAJAN, MEERA
`2293.1220001mAcna-HM-s
`
`NON PATENT LITERATURE DOCUMENTS
`
`73 (1 5) :4820-4829, American Association Cancer Research, United States (2013)
`
`Examiner
`Initials*
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog, etc.),
`date, page(s), volume-issue number(s), publisher, city and/or country where published
`
`T2
`
`DANGAJ, D., et al., “Novel Recombinant human B7 -H4 antibodies overcome tumoral
`immune escape to potentiate T cell anti-tumor responses,” Cancer Research
`
`9743 974_l .dOCX
`
`Examiner
`
`Signature
`
`Date
`
`Considered
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance
`and not considered. Include copy of this form with next communication to applicant.
`1 Applicant’s unique citation designation number (optional). 2 Applicant is to place a check mark here if English language Translation is attached.
`
`